David Mark Steinhaus
Direktor/Vorstandsmitglied bei EBR SYSTEMS, INC.
Profil
David Mark Steinhaus is currently the Executive Chairman at Enopace Biomedical Ltd.
He is also an Independent Non-Executive Director at EBR Systems, Inc. and a Director at Qardio, Inc. Dr. Steinhaus previously worked as the VP & General Manager-Heart Failure Business at Cardiac Rhythm & Heart Failure.
He holds a doctorate degree from Harvard Medical School and an undergraduate degree from Harvard College.
Aktive Positionen von David Mark Steinhaus
Unternehmen | Position | Beginn |
---|---|---|
EBR SYSTEMS, INC. | Direktor/Vorstandsmitglied | 08.11.2021 |
Enopace Biomedical Ltd.
Enopace Biomedical Ltd. Medical SpecialtiesHealth Technology Enopace Biomedical Ltd. develops medical devices to treat heart failure patients. The firm's technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload and improves the systolic/diastolic ratio. The company was by Yossi Gross and Amir Dagan in 2008 and is headquartered in Caesarea, Israel. | Vorsitzender | - |
Qardio, Inc.
Qardio, Inc. Medical DistributorsDistribution Services Qardio, Inc. engages in the provision of wearable applications including heart monitoring devices to track health. It offers healthcare solutions for patients, doctors, and healthcare providers. The company was founded by Marco Peluso and Rosario Iannella in 2012 and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | 10.08.2022 |
Ehemalige bekannte Positionen von David Mark Steinhaus
Unternehmen | Position | Ende |
---|---|---|
Cardiac Rhythm & Heart Failure | Corporate Officer/Principal | - |
Ausbildung von David Mark Steinhaus
Harvard Medical School | Doctorate Degree |
Harvard College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
EBR SYSTEMS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Enopace Biomedical Ltd.
Enopace Biomedical Ltd. Medical SpecialtiesHealth Technology Enopace Biomedical Ltd. develops medical devices to treat heart failure patients. The firm's technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload and improves the systolic/diastolic ratio. The company was by Yossi Gross and Amir Dagan in 2008 and is headquartered in Caesarea, Israel. | Health Technology |
Qardio, Inc.
Qardio, Inc. Medical DistributorsDistribution Services Qardio, Inc. engages in the provision of wearable applications including heart monitoring devices to track health. It offers healthcare solutions for patients, doctors, and healthcare providers. The company was founded by Marco Peluso and Rosario Iannella in 2012 and is headquartered in San Francisco, CA. | Distribution Services |
Cardiac Rhythm & Heart Failure |